Ascent is an international full-service CRO combined with SMO that provides an entire range of clinical research services from Phase I-II-III to Bioequivalence studies and post-marketing observation programs for world’s leading biopharmaceutical companies.
We conduct studies in our own dedicated hospital-based clinical pharmacology units and under multicenter set-ups in Russia and Georgia.
Ascent CRS offers Sponsors exceptional fast recruitment rates for patient populations in the following therapeutic areas: Oncology, Cardiovascular, Metabolic, Respiratory, Neurology, Infectious diseases, Immune diseases, Gastro Intestinal, Urology, Kidney diseases, Liver diseases.
We have an excellent operational team of study physicians and project managers, all of them are MDs/PhDs with outstanding expertise in exploratory clinical research. Our team has proudly contributed to more than 300 projects over the last 10 years.
Ascent CRS has broad experience in conducting most comprehensive clinical studies with challenging logistics and rare patient groups.
We have developed strong partnerships with most reputable universities and hospitals in Moscow, Russia and Tbilisi, Georgia for various drug development projects.
Combination of exceptional recruitment speed, unsurpassed quality and level of expertise makes Ascent CRS truly unique.
Our team deals with challenges of global clinical studies, regardless of size or complexity.